Patents by Inventor Ian PASS

Ian PASS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260130902
    Abstract: Disclosed herein are compounds that abrogate the activity of HIPK4 by inhibiting the enzyme, inducing its degradation, or both. Also disclosed are methods for using the disclosed compounds as male contraceptives.
    Type: Application
    Filed: November 5, 2025
    Publication date: May 14, 2026
    Inventors: James Kenneth Chen, Zaile Zhuang, Thomas D.Y. Chung, Patrick C. Kearney, Ian Pass, Andrey Bobkov, Shubhankar Dutta
  • Patent number: 10272074
    Abstract: Provided herein are compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of Glucocorticoid Receptor (GR) translocation. Furthermore, the subject compounds and compositions are useful for the treatment of diseases involved in the hypothalamic-pituitary-adrenal (HPA) axis.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: April 30, 2019
    Assignee: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
    Inventors: Anthony B. Pinkerton, Christian A. Hassig, Michael R. Jackson, Robert John Ardecky, Ian Pass
  • Publication number: 20180207140
    Abstract: Provided herein are compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of Glucocorticoid Receptor (GR) translocation. Furthermore, the subject compounds and compositions are useful for the treatment of diseases involved in the hypothalamic-pituitary-adrenal (HPA) axis.
    Type: Application
    Filed: January 28, 2016
    Publication date: July 26, 2018
    Inventors: Anthony B. PINKERTON, Christian A. HASSIG, Michael R. JACKSON, Robert John ARDECKY, Ian PASS